Monitoring platforms that track the spread of the virus, passive vaccines, clinical trials and drone deliveries are a few of the spectrum of technologies used by Israel to fight against the pandemic. By Team Viva
Researchers, business professionals and innovators of various countries around the globe are using technology to alleviate the effects of the global health crisis.
From monitoring platforms that track the spread of the virus to finding passive vaccines to clinical trials to drone deliveries — these are a few of the different technology projects used by Israel to fight Coronavirus.
COVID-19 remote assessment and monitoring platform
It is a triage and monitoring platform that allows officials to monitor the progress of the disease and alerts health providers of patients at risk. A symptomatic Coronavirus heat map is leveraged to locate Coronavirus symptomatic patients, and track the path of the pandemic. The information provides data-based guidance on next steps for patients, providers and public health agencies.
Currently it is in-use with the Ministry of Health, the emergency services, and all major HMOs in Israel, with the Department of Health in the State of Odisha, India, and with the Department of Health in the State of Rhode Island. Diagnostic Robotics has partnered with Deloitte and Salesforce for seamless integration to all Salesforce customers and is a member of the COVID-19 Healthcare Coalition, alongside Amazon, Google, Mayo Clinic and others.
It provides an AI layer for the healthcare system, providing services to patients, providers and insurers. Their AI-driven personalised triage system guides the patients through their journey in the medical ecosystem, analysing their medical history and current medical case using AI and NLP technologies, with generic ability to integrate with multiple sensory output data.
The Israeli Ministry of Health has developed a COVID-19 strategy which includes daily nation-wide monitoring of Coronavirus related symptoms of the population using Diagnostic Robotics digital risk assessment and monitoring platform for COVID-19, screening eight million patients daily.
Drone deliveries
Drone technology company Flytrex, in partnership with EASE Drones, the Grand Forks Region Economic Development Corporation and the City of Grand Forks, announced the launch of its drone delivery service directly to backyards in Grand Forks, North Dakota. The initiative will provide food, medicine and other essential goods via drone to selected households.
The deliveries will be made in cooperation with the Northern Plains Unmanned Aerial System Test Site (NPUASTS), with takeoffs taking place across the street from a local shopping supercenter, where provisions will be purchased. “In this time of crisis and social distancing, drones provide the ideal solution to bolster delivery capacity while keeping citizens safe at home,” said Flytrex CEO Yariv Bash.
Power the video experience
Kaltura has emerged as the fastest growing video platform. Various companies are using it to build knowledge, improve team productivity and collaborate. It also engages viewers and facilitates the delivery of message more effectively. From executive messaging to live streaming of events, it ensures high quality, reliable playback for viewers and powerful, easy-to-use tools for producers. Kaltura also trains employees, faster, and more cost effectively.
Mobile sports training platform
Legend is an immersive mobile sports training platform that engages young athletes, by providing a virtual, AI driven, trainer. It enables the young athletes to train and compete with their friends and participate in the global community through unique daily and weekly workouts, challenges and competitions.
Plasma-Derived Anti-Corona Immunoglobulin (passive vaccine)
Kamada is developing an anti-Corona (SARS-COV-2) immunoglobulin (passive vaccine) using its proprietary plasma derived FDA-approved platform technology, as a potential treatment for patients from the disease. The product is being produced from plasma donated by patients recovering from COVID-19, which is expected to include antibodies to the Coronavirus.
Clinical trials
Pluristem Therapeutics (NASDAQ, TASE: PSTI) is a leading regenerative medicine company developing a platform of novel biological products candidates. The company has reported robust clinical trial data in multiple indications and is currently conducting late stage clinical trials in several indications.